The development of advanced genetic research, molecular diagnostics, and nucleic acid-based therapies is increasing the importance of oligonucleotide synthesis in biotechnology. These short DNA or RNA sequences are used in applications ranging from polymerase chain reaction (PCR) testing and DNA sequencing to gene editing and therapeutic development. As pharmaceutical companies and research institutions expand their work in precision medicine, demand for specialized synthesis services and high-quality oligonucleotides continues to increase. The oligonucleotide synthesis market was valued at USD 3.6 billion in 2025 and is projected to grow from USD 4.1 billion in 2026 to USD 10.9 billion by 2033, registering a compound annual growth rate (CAGR) of 14.9% from 2026 to 2033.

Download a free sample copy of the Oligonucleotide Synthesis market report to understand detailed coverage and inclusions in the final report

Therapeutic Research Creates New Market Opportunities

The growing development of nucleic acid-based therapies is a major factor supporting market expansion. Antisense oligonucleotides, small interfering RNA (siRNA), and other genetic approaches require precisely designed sequences to target specific biological processes. Advances in gene editing, including CRISPR-based technologies, are also increasing the need for reliable DNA and RNA synthesis.

Pharmaceutical and biotechnology companies are investing in research programs that explore oligonucleotides for therapeutic applications. As these programs progress from laboratory research toward clinical development, the need for customized, high-quality, and scalable manufacturing capabilities is increasing. These requirements create opportunities for synthesis providers to support drug discovery, preclinical research, and clinical development.

Services Lead the Product and Service Landscape

The services segment accounted for 38.1% of market revenue in 2025, making it the largest product and service category. Outsourcing synthesis enables pharmaceutical companies, biotechnology firms, and research laboratories to access specialized manufacturing expertise without establishing all the required infrastructure internally.

The services segment is also projected to grow at the fastest CAGR during the forecast period. Increasing demand for customized sequences, chemically modified oligonucleotides, and production that meets stringent quality requirements is supporting this growth. Specialized providers can help customers manage complex synthesis requirements while addressing quality control and scalability needs.

Equipment, reagents, and oligonucleotide products also remain essential components of the market. Continued improvements in synthesis technologies and manufacturing processes are helping providers meet evolving requirements across research and commercial applications.

PCR Primers Support Application Demand

PCR primers represented 20.6% of market revenue in 2025, supported by their role in DNA amplification, genetic analysis, and molecular diagnostics. They are used in techniques such as quantitative PCR, reverse transcription PCR, and digital PCR, making them important tools for research laboratories and diagnostic applications.

Sequencing is expected to be the fastest-growing application segment. Expanding genomics research, improvements in sequencing technologies, and growing demand for genetic analysis are creating additional opportunities. Researchers increasingly require accurately designed oligonucleotides to support gene identification, pathogen detection, and other molecular biology workflows.

Academic Research Institutes Remain Major End Users

Academic research institutes accounted for 44.5% of market revenue in 2025, reflecting the importance of oligonucleotides in gene editing, PCR, mutagenesis, diagnostics, and molecular biology studies. Universities and research centers use synthesized sequences in experimental research and the development of new scientific methods.

Pharmaceutical and biotechnology companies are expected to record the fastest growth among end-use segments. Their expanding work in targeted therapies, genetic medicine, and drug development is increasing demand for specialized oligonucleotides that can support complex research and clinical programs.

North America Leads While Asia Pacific Expands

North America held 40.4% of market revenue in 2025, supported by established biotechnology and pharmaceutical industries, research institutions, and demand for advanced molecular technologies.

Asia Pacific is projected to be the fastest-growing regional market, with a CAGR of 17.9% from 2026 to 2033. Investments in biotechnology, genomics research, and local manufacturing capabilities are supporting regional expansion. China held the largest country-level market share in 2025, while growing research infrastructure across the region is creating further opportunities.

Quality Standards Shape Competitive Strategies

Manufacturers face challenges associated with synthesis accuracy, production scalability, regulatory requirements, and good manufacturing practice (GMP) compliance. Meeting these requirements can increase production complexity and costs, particularly for therapeutic-grade materials. Companies are responding through process improvements, expanded production capabilities, strategic partnerships, and investments in advanced synthesis technologies.

Overall, the oligonucleotide synthesis market is positioned for substantial growth as genetic research, molecular diagnostics, and nucleic acid-based therapies advance. Demand for specialized services, sequencing applications, and high-quality manufacturing is expected to remain central to market development through 2033.

Frequently Asked Questions

1. How big is the oligonucleotide synthesis market?

The market was valued at USD 3.6 billion in 2025 and is projected to reach USD 10.9 billion by 2033, growing at a CAGR of 14.9% from 2026 to 2033.

2. Which region is expected to grow fastest in the oligonucleotide synthesis market?

Asia Pacific is projected to be the fastest-growing regional market, with a CAGR of 17.9% from 2026 to 2033.

Key Oligonucleotide Synthesis Companies:

Thermo Fisher Scientific Inc.
Merck KGaA
Danaher
Revvity Discovery Limited

Explore the full list of profiled companies operating in this market with recent strategic initiatives

About us:

Grand View Research, a market research and consulting company, provides syndicated research reports, customized research reports, and consulting services. Grand View Research database is used by the world's renowned academic institutions and Fortune 500 companies to understand the global and regional business environment. Our database features thousands of statistics and in-depth analysis on 46 industries in 25 major countries worldwide.

What Is Driving Growth in the Oligonucleotide Synthesis Market?

The global oligonucleotide synthesis market size was valued at USD 3.6 billion in 2025 and is projected to grow from USD 4.1 billion in 2026 to USD 10.9 billion